Partial breast re-irradiation using ultra hypofractionation (PRESERVE) Phase 2 multi-institutional study
Sponsor: |
Canadian Cancer Society |
Enrolling: |
Male and Female Patients |
IRB Number: |
AAAV5572 |
Contact: |
Christina Chesnakov: / cc4047@cumc.columbia.edu |
The purpose of this study is to see if a 1-week course of radiation therapy, called hypofractionated radiation therapy, is a safe and effective option for women with localized recurrent breast cancer who have already had radiation treatment. Hypofractionated radiation therapy is a type of cancer treatment that involves delivering a larger dose of radiation in fewer sessions. Normally, radiation for breast cancer involves smaller doses given over many sessions, often taking several weeks to complete. However, studies in women with newly diagnosed breast cancer (who haven't had radiation before) have shown that receiving fewer treatments with higher daily doses can be just as effective, more convenient, and cause fewer short-term side effects. This study aims to find out if hypofractionated radiation therapy is also a good option for women with recurrent breast cancer. If successful, it could provide a faster and easier treatment alternative to the traditional longer radiation schedule.
This study is closed
Investigator
Eileen Connolly, MD, PhD
Are you 18 years or older? |
Yes |
No |
have you been diagnosed with in-breast recurrence of DCIS or invasive carcinoma? |
Yes |
No |